Sunil Kumar Panigrahi

This inventor holds 16 USPTO granted patents and 10 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Asana Biosciences, LLC, Aurigene Discovery Technologies Limited, Endo Pharmaceuticals Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sunil Kumar Panigrahi. Retrieved from https://idiyas.com/inventor/sunil-kumar-panigrahi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 10)

% Patents Active = 56.3

EPO Patents = 6 (Patent Applications = 12)

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Kantamal, IN (2015)
Orissa, IN (2014 - 2021)
Boudh, IN (2013 - 2023)

Company Filing History:

7 out of 34

Asana Biosciences, LLC

patents

4 out of 45

Aurigene Discovery Technologies Limited

patents

2 out of 32

Endo Pharmaceuticals Inc.

patents

4. 2 out of 4

Um Pharmauji Sdn. Bhd.

patents

5. 1 out of 1

Asan Biosciences, LLC

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

TEAD Transcription Factors

PRMT5 Inhibitors

Dihydroorotate Oxygenase

RAS Pathway

RAF Pathway

MEK

ERK

PI3K

AKT

mTOR

Pyrimido-Pyridazinone

Quinazolines

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187722 - Small molecule inhibitors of TEAD transcription factors (2025-01-07),

2. 11542275 - Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors (2023-01-03),

3. 11365205 - Imidazolidin-2-one compounds as PRMT5 modulators (2022-06-21),

4. 11028054 - 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors (2021-06-08),

5. 10912779 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2021-02-09),

6. 10647720 - Pyrimido-pyridazinone compounds and methods of use thereof (2020-05-12),

7. 10226468 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2019-03-12),

8. 10183944 - Pyrimido-pyridazinone compounds and methods of use thereof (2019-01-22),

9. 9757382 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2017-09-12),

10. 9499495 - Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways (2016-11-22),

11. 9382277 - Pyrimido-pyridazinone compounds and methods of use thereof (2016-07-05),

12. 9115092 - Substituted quinazoline and pyrido-pyrimidine derivatives (2015-08-25),

13. 9062075 - Tetrahydropyridine derivatives as FabI inhibitors (2015-06-23),

14. 9062002 - Substituted pyridine derivatives as FabI inhibitors (2015-06-23),

15. 8729079 - Pyrimido-pyridazinone compounds and methods of use thereof (2014-05-20),

Title: Sunil Kumar Panigrahi - Innovator from Orissa, IN

Introduction: Sunil Kumar Panigrahi is a renowned inventor hailing from Orissa, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sunil Kumar Panigrahi holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare technologies.

Career Highlights: With a career spanning over two decades, Sunil Kumar Panigrahi has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Sunil Kumar Panigrahi has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Sunil Kumar Panigrahi's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.